Literature DB >> 17460372

Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003).

Kunitoshi Iseki1, Kentaro Kohagura, Atsushi Sakima, Chiho Iseki, Kozen Kinjo, Yoshiharu Ikemiya, Shuichi Takishita.   

Abstract

To compare the risk factor demographics and the prevalence of chronic kidney disease (CKD), we analyzed two databases from the 1993 (N=143,948) and 2003 (N=154,019) mass screenings in Okinawa, Japan (Okinawa General Health Maintenance Association registry). We estimated the glomerular filtration rate (GFR) using serum creatinine (SCr) levels. SCr was measured by the modified Jaffe method in 1993 and by enzyme assay in 2003; the relation between the two methods was: SCr (Jaffe) = 0.194 + 1.079 x SCr (enzyme). CKD prevalence was compared using the estimated GFR calculated by the abbreviated Modification of Diet in Renal Disease (MDRD) equation. SCr was measured in 66.2% (1993) and 69.8% (2003) of the total screenees. Proteinuria was present in 3.4% (1993) and 4.3% (2003) of the total screened population, respectively. The prevalence of CKD (GFR<60 ml/min/1.73 m(2)) was similar between the two databases, being 15.7% in 1993 and 15.1% in 2003. However, the demographics of the CKD risk factors changed during the study period. The mean level of systolic blood pressure decreased, whereas the prevalence of obesity and the mean levels of serum cholesterol and fasting plasma glucose increased. In 2003, the estimated prevalence of metabolic syndrome in the general population of Japan calculated using the modified National Cholesterol Education Program (NCEP) criteria was 19.1%. The prevalence of CKD was significantly associated with that of metabolic syndrome: the age- and sex-adjusted odds ratio was 1.332 (95% confidence interval [CI], 1.277-1.389; p<0.0001). In conclusion, the demographics of the participants of the general screenings in Okinawa, Japan differed between the 1993 and 2003 screenings, but the prevalence of CKD seemed to be similar, or at least did not increase substantially, between the two databases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460372     DOI: 10.1291/hypres.30.55

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  11 in total

1.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

2.  Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.

Authors:  Taku Inoue; Kunitoshi Iseki; Chiho Iseki; Yusuke Ohya; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2009-05-15       Impact factor: 2.801

3.  Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Kaori Tokashiki; Chiho Iseki; Kentaro Kohagura; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2008-06-27       Impact factor: 2.801

4.  Decreased body mass index as an independent risk factor for developing chronic kidney disease.

Authors:  Kaori Tokashiki; Masahiko Tozawa; Chiho Iseki; Kentaro Kohagura; Kozen Kinjo; Shuichi Takishita; Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2008-10-07       Impact factor: 2.801

5.  Risk factors for chronic kidney disease in Japan: a community-based study.

Authors:  Norimichi Takamatsu; Hideharu Abe; Tatsuya Tominaga; Kunihiko Nakahara; Yumi Ito; Yoko Okumoto; Jiyoong Kim; Masafumi Kitakaze; Toshio Doi
Journal:  BMC Nephrol       Date:  2009-10-27       Impact factor: 2.388

6.  Age and association of kidney measures with mortality and end-stage renal disease.

Authors:  Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

7.  Burden and management of chronic kidney disease in Japan: systematic review of the literature.

Authors:  Karin Travers; Amber Martin; Zarmina Khankhel; Kristina S Boye; Lauren J Lee
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-01-03

8.  End-stage renal disease in Taiwan: a case-control study.

Authors:  Su-Ying Tsai; Hung-Fu Tseng; Hsiu-Fen Tan; Yu-Shu Chien; Chia-Chu Chang
Journal:  J Epidemiol       Date:  2009-06-20       Impact factor: 3.211

9.  Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.

Authors:  Chi Pang Wen; Kunihiro Matsushita; Josef Coresh; Kunitoshi Iseki; Muhammad Islam; Ronit Katz; William McClellan; Carmen A Peralta; HaiYan Wang; Dick de Zeeuw; Brad C Astor; Ron T Gansevoort; Andrew S Levey; Adeera Levin
Journal:  Kidney Int       Date:  2014-02-12       Impact factor: 10.612

10.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

Authors:  Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.